Access to antibiotics: A safety and equity challenge for the next decade

Antimicrobial Resistance and Infection Control

Volumn 2, Issue 1, 2013, Pages

  Carlet, Jean ^a,b   Pittet, Didier ^c  

^a World Alliance Against Antibiotic Resistance (WAAAR)   (France)

^b SAINT JOSEPH HOSPITAL   (France)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Antibiotics; Antibiotics use; Antimicrobial resistance; Antimicrobial resistance surveillance; Multidrug resistant organisms

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; COLISTIN; PENICILLIN DERIVATIVE;

ABDOMINAL INFECTION; ACINETOBACTER; ANTIBIOTIC RESISTANCE; DRUG MISUSE; DRUG SAFETY; ESCHERICHIA COLI; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HUMAN; KLEBSIELLA PNEUMONIAE; MEDICAL DECISION MAKING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MORBIDITY; MORTALITY; NOTE; PATIENT SAFETY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PYELONEPHRITIS; RISK BENEFIT ANALYSIS; TREATMENT INDICATION; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84901493076     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/2047-2994-2-1     Document Type: Note

References (28)

1. Carlet J, Collignon P, Goldmann D, Goossens H, Gyssens IC, Harbarth S, Jarlier V, Levy SB, N'Doye B, Pittet D, Richtmann R, Seto WHO, Van der Meer JWM, Voss A. Society's failure to protect a precious resource: antibiotics. Lancet 2011, 378(9788):369-371. 10.1016/S0140-6736(11)60401-7, 21477855.
2. Hughes JM. Preserving the lifesaving power of antimicrobial agents. JAMA 2011, 305(10):1027-1028. 10.1001/jama.2011.279, 21343545.
3. Piddock LJ. The crisis of no new antibiotics-what is the way forward. Lancet Infect Dis 2012, 12(3):249-253. 10.1016/S1473-3099(11)70316-4, 22101066.
4. Bush K, Courvalin P, Gautam D, Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, Huovinen P, Jacoby GA, Kishony R, Kreiswirth BN, Kutter E, Lerner SA, Levy S, Lewis K, Lomovskaya O, Miller JH, Mobashery S, Piddock LJ, Projan S, Thomas CM, Tomasz A, Tulkens PM, Walsh TR, Watson JD, Witkowski J, Witte W, Wright G, Yeh P, Zgurskaya HI. Tackling antibiotic resistance. Nat Rev Microbiol 2011, 9(12):894-895. 10.1038/nrmicro2693, 22048738.
5. Allegranzi B, Bagheri-Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, Pittet D. Burden of endemic healthcare-associated infection in developing countries: systematic review and meta-analysis. Lancet 2011, 377(9761):228-241. 10.1016/S0140-6736(10)61458-4, 21146207.
6. Vlieghe E. The First Global Forum on Bacterial Infections calls for urgent action to contain antibiotic resistance. Expert Rev Anti Infect Ther 2012, 10(12):145-148.
7. Rossolini GM, Mantengoli E, Docquier JD, Musmanno RA, Coratza G. Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains. New Microbiol 2007, 30(2):332-339.
8. Carlet J, Mainardi JL. Antibacterial agents: back to the future. Can we live with only colistin, co-trimoxazole, and fosfomycin. Clin Microbiol Infect 2012, 18(1):1-3. 10.1111/j.1469-0691.2011.03702.x, 23137133.
9. Matthaiou DK, Michalopoulos A, Rafailidis PI, Karageorgopoulos DE, Papaioannou V, Ntani G, Samonis G, Falagas ME. Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Care Med 2008, 36(3):807-811. 10.1097/CCM.0B013E3181652FAE, 18431267.
10. Deleo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 2010, 375(9725):1557-1568. 10.1016/S0140-6736(09)61999-1, 3511788, 20206987.
11. Meir S, Weber R, Zbinden R, Ruef C, Hasse B. Extended-spectrum beta-lactamases producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection 2011, 39(4):333-340. 10.1007/s15010-011-0132-6, 21706226.
12. Kumarasamy KK, Toleman MA, Walsh TR. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010, 10(9):597-602. 10.1016/S1473-3099(10)70143-2, 2933358, 20705517.
13. Perez F, Bonomo RA. Can we really use beta-lactam/beta-lactam inhibitor combinations for the treatment of infections caused by extended-spectrum beta-lactamase-producing bacteria. Clin Infect Dis 2012, 54(2):175-177. 10.1093/cid/cir793, 22057699.
14. Bassetti M, Ginocchio F, Mikulska M, Taramasso L, Giacobbe DR. Will new antimicrobials overcome resistance among Gram-negatives. Expert Rev Anti Infect Ther 2011, 9(10):909-922. 10.1586/eri.11.107, 21973303.
15. European Centre for Disease Prevention and Control (ECDC) and European Medicines Agency (EMEA) ECDC/EMEA joint technical paper: the bacterial challenge, time to react 2009, Stockholm, Sweden, http://www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf; accessed December 14, 2012, European Centre for Disease Prevention and Control (ECDC) and European Medicines Agency (EMEA).
16. European Centre for Disease Prevention and Control ECDC daily update. 2009 influenza A (h1N1) pandemic 2010, http://ecdc.europa.eu/en/healthtopics/Documents/100119_Influenza_AH1N1_Situation_Report_0900hrs.pdf; accessed December 17, 2012, European Centre for Disease Prevention and Control.
17. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36(1):296-327. 10.1097/01.CCM.0000298158.12101.41, 18158437, International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine.
18. Levy MM, Dellinger PR, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC, Surviving Sepsis Campaign The Surviving Sepsis Campaign: results of an international guideline-guided performance improvement program targeting severe sepsis. Crit Care Med 2010, 38(2):67-74. Surviving Sepsis Campaign.
19. Van Gastel E, Costers M, Peetermans WE, Struelens MJ, Hospital Medicine Working Group of the Belgian Antibiotic Policy Coordination Committee Nationwide implementation of antibiotic management teams in Belgian hospitals: a self-reporting survey. J Antimicrob Chemother 2010, 65(3):576-580. 10.1093/jac/dkp470, 20053695, Hospital Medicine Working Group of the Belgian Antibiotic Policy Coordination Committee.
20. Antibiotic therapy and prevention of bacterial resistance in healthcare organisations 2008, http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-03/antibiotic_therapy_and_prevention_of_bacterial_resistance_-_guidelines.pdf; accessed December 14, 2012, Antibiotic therapy and prevention of bacterial resistance in healthcare organisations.
21. Loveday HP, Pellowe CM, Jones SR, Pratt RJ. A systematic review of the evidence for interventions for the prevention and control of meticillin-resistant Staphylococcus aureus (1996-2004): report to the Joint MRSA Working Party (Subgroup A). J Hosp Infect 2006, 63(Suppl 1):S45-S70.
22. Ofner-Agostini M, Varia M, Johnston L, Green K, Simor A, Amihod B, Bryce E, Henderson E, Stegenga J, Bergeron F, Canadian Nosocomial Infection Surveillance Program, Gravel D Infection control and antimicrobial resistance practices for antmicrobial-resistant organisms in Canadian tertiary care hospitals. Am J Infect Control 2007, 35(9):563-568. 10.1016/j.ajic.2006.12.003, 17980232, Canadian Nosocomial Infection Surveillance Program, Gravel D.
23. Anthony F, Acar J, Franklin A, Gupta R, Nicholls T, Tamura Y, Thompson S, Threlfall EJ, Vose D, van Vuuren M, White DG, Office International des Epizooties Ad hoc Group Antimicrobial resistance: responsible and prudent use of antimicrobial agents in veterinary medicine. Rev Sci Tech 2001, 20(3):829. Office International des Epizooties Ad hoc Group.
24. Wernitz MH, Swidsinski S, Weist K, Sohr D, Witte W, Franke KP, Roloff D, Rüden H, Veit SK. Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clin Microbiol Infect 2005, 11(6):457-465. 10.1111/j.1469-0691.2005.01152.x, 15882195.
25. Carlet J, Astagneau P, Brun-Buisson C, Coignard B, Salomon V, Tran B, Desenclos JC, Jarlier V, Schlemmer B, Parneix P, Regnier B, Fabry J, French National Program for Prevention of Healthcare-Associated Infections and Antimicrobial Resistance French national program for prevention of healthcare-associated infections and antimicrobial resistance 1992-2008: positive trends, but perseverance needed. Infect Control Hosp Epidemiol 2009, 30(8):737-745. 10.1086/598682, 19566444, French National Program for Prevention of Healthcare-Associated Infections and Antimicrobial Resistance.
26. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, Schlosser J, Martone WJ. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996, 275(3):234-240. 10.1001/jama.1996.03530270074035, 8604178.
27. Degos L, Amalberti R, Bacou J, Carlet J, Bruneau C. Breaking the mould in patient safety. BMJ 2009, 338:2585.
28. World Health Organization The evolving threat of antimicrobial resistance - options for action 2012, Geneva: WHO, http://whqlibdoc.who.int/publications/2012/9789241503181_eng.pdf; accessed December 14, 2012, World Health Organization.